SEC Form 4 · accession 0001437749-19-001055
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles K Dargan
Officer — Chief Financial Officer
Period of report
Jan 16, 2019
Accepted (ET)
Jan 18, 2019 · 3:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880242
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option AgreementF1 | $0.223 | Jan 16, 2019 | A | 300,000 | A | Jan 16, 2019 | Jan 16, 2029 | Common Stock | 300,000 | 3,206,000 | D |
Explanation of responses
- F1This Option was issued to the Reporting Person as the sole compensation to serve as Issuer's Chief Financial Officer for the one year period ending September 30, 2019.